Thursday, 08 February 2024
A team of scientists and experts have been awarded funding to evaluate the new National Health Service (NHS) Pharmacy First service.
Researchers led by London School of Hygiene and Tropical Medicine in collaboration with the 糖心原创 and Universities of Manchester and Oxford and experts at the UK Health Security Agency (UKHSA), have been awarded £2.4m by the National Institute for Health and Care Research (NIHR) to evaluate the new service introduced to allow pharmacies to prescribe for minor illnesses.
The under the Government’s NHS Primary Care Recovery Plan. From February 2024, participating pharmacies will be able to supply prescription-only medicines for seven common conditions: earache, uncomplicated urinary tract infections in women, sore throat, sinusitis, impetigo, shingles and infected insect bites, after consultation with a community pharmacist.
The research team will evaluate Pharmacy First's take-up, safety, equity, cost effectiveness and acceptability, as well as its implications for antibiotic use and antimicrobial resistance.
I鈥檓 excited to work with a research team including cross-discipline expertise from pharmacists, general practitioners, nurses, health economists, policy researchers, and experts in antimicrobial resistance to evaluate a new community pharmacy service that puts patients first.
I am delighted to be part of the team evaluating Pharmacy First in England. We will have much to learn from similar, successful schemes in Wales and Scotland
Professor Rachel Elliot, lead for the Manchester Centre for Health Economics said: "I am looking forward to working on the evaluation of Pharmacy First. When resources are limited in the NHS, it is essential we spend that money on safe and effective services to make sure patients get the best value for money from their healthcare."
Community pharmacies aree important providers of healthcare and are accessible to all communities, including the medically-underserved. This evaluation will contribute to understanding possible consequences of Pharmacy First for inequalities in access to health services and outcomes.
Story credits
More information from Kimberley Sonnex on Kimberley.Sonnex@nottingham.ac.uk
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.